UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000024658 |
|---|---|
| Receipt number | R000028366 |
| Scientific Title | Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension |
| Date of disclosure of the study information | 2016/11/01 |
| Last modified on | 2016/10/31 20:20:39 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension
Acronym
Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension
Scientific Title
Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension
Scientific Title:Acronym
Nursing research on pain associated with subcutaneous Treprostinil Therapy in patients with pulmonary arterial hypertension
Region
| Japan |
Condition
Condition
pulmonary arterial hypertension
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Clarify the problems of nursing care in pain management to the Cardiology definitive Treprostinil continuous subcutaneous administration patient.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
pain
Key secondary outcomes
Base
Study type
Others,meta-analysis etc
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Patients who had done Treprostinil continuous subcutaneous administration from October 2015 until June 2016.
Key exclusion criteria
Not set for the case study.
Target sample size
2
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Chie Myouchin |
Organization
hospital
Division name
West 9 floor
Zip code
Address
1-1 Seryoutyou Aoba-ku Sedai-shi Miyagi-ken 8574-980
TEL
022-717-7786
dbfhw551@yahoo.co.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Chie Myouchin |
Organization
Tohoku University
Division name
West 9 Floor
Zip code
Address
1-1 Seryoutyou Aoba-ku Sedai-shi Miyagi-ken 8574-980
TEL
022-7171-7786
Homepage URL
dbfhw551@yahoo.co.jp
Sponsor or person
Institute
Tohoku University Hospital
Institute
Department
Personal name
Funding Source
Organization
Tohoku University Hospital
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 11 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Preinitiation
Date of protocol fixation
| 2016 | Year | 10 | Month | 31 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 11 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
In the west 9 floor ward researchers belong, to target the two patients who started the Trepurostinil continuous subcutaneous administration to pulmonary hypertension. Symptoms from the October 2015 first case of the subject was admitted to the second example in June 2016 by the subject was discharged of, about the contents of the implementation nursing intervention, information collected from nursing records and medical records. Lack of information to supplement with your recorder. Further, based on the data obtained from nursing records and medical records, summarized in chronological nursing interventions
Management information
Registered date
| 2016 | Year | 10 | Month | 31 | Day |
Last modified on
| 2016 | Year | 10 | Month | 31 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000028366
